Syndax Pharmaceuticals Inc (SNDX)
Cost of Revenue
$3.21M
Quarterly · Period ending: · USD
SNDX Cost of Revenue
Latest reported$3.21Mperiod ending
Latest reported$3.21Mperiod ending
SNDX Quarterly Cost of Revenue ($0.00 → $3.21M)
Quarterly cost of revenue
High-resolution chart · PNG
SNDX cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 3,208,000 | |
| 2,633,000 | |
| -1,572,000 | |
| 2,100,000 | |
| 1,279,000 | |
| 885,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 121,000 | |
| 0 | |
| 0 | |
| 0 | |
| 1,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 600,000 | |
| 600,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |